These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 24650058

  • 1. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M, Dall'Agata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, Ravaioli M, Gambato M, Montalti R, Pinna AD, Burra P, Gerunda GE, Cillo U, Andreone P, Bernardi M.
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [Abstract] [Full Text] [Related]

  • 2. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, Ghodssi-Ghassemabadi R, Azmoudeh-Ardalan F, Nedjat S.
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [Abstract] [Full Text] [Related]

  • 3. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC, Liver Transplantation Group.
    Clin Transplant; 2012 Feb; 26(4):E395-401. PubMed ID: 22882694
    [Abstract] [Full Text] [Related]

  • 4. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?
    Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M.
    Liver Transpl; 2010 Aug; 16(8):964-73. PubMed ID: 20677287
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 6. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [Abstract] [Full Text] [Related]

  • 7. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.
    Iacob S, Gheorghe L, Iacob R, Gheorghe C, Hrehoreţ D, Popescu I.
    Chirurgia (Bucur); 2009 Oct; 104(3):267-73. PubMed ID: 19601457
    [Abstract] [Full Text] [Related]

  • 8. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ, Gish RG, Ahmed A.
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [Abstract] [Full Text] [Related]

  • 9. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Dec; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 10. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.
    BMC Gastroenterol; 2009 Sep 25; 9():72. PubMed ID: 19778459
    [Abstract] [Full Text] [Related]

  • 11. Does model for end-stage liver disease (MELD) require modification?
    Desai HG.
    J Assoc Physicians India; 2011 Jun 25; 59():372-3. PubMed ID: 21751591
    [Abstract] [Full Text] [Related]

  • 12. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.
    Ecochard M, Boillot O, Guillaud O, Roman S, Adham M, Mion F, Dumortier J.
    Clin Transplant; 2011 Jun 25; 25(5):755-65. PubMed ID: 21158918
    [Abstract] [Full Text] [Related]

  • 13. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov 25; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 14. LIRER score - a valuable tool to predict medium-long-term outcomes in hepatic cirrhosis decompensation.
    Freitas M, Xavier S, Magalhães R, Magalhães J, Marinho C, Cotter J.
    Scand J Gastroenterol; 2020 Sep 25; 55(9):1079-1086. PubMed ID: 32715829
    [Abstract] [Full Text] [Related]

  • 15. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep 25; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 16. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb 25; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 17. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP, Tandon P, Ney M, Meeberg G, Faris P, Shaheen AA, Aspinall AI, Burak KW.
    Liver Int; 2014 Sep 25; 34(8):1176-83. PubMed ID: 24256642
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis.
    Kalra A, Wedd JP, Bambha KM, Gralla J, Golden-Mason L, Collins C, Rosen HR, Biggins SW.
    Liver Transpl; 2017 Feb 25; 23(2):155-165. PubMed ID: 28006875
    [Abstract] [Full Text] [Related]

  • 19. Serum sodium and survival benefit of liver transplantation.
    Sharma P, Schaubel DE, Goodrich NP, Merion RM.
    Liver Transpl; 2015 Mar 25; 21(3):308-13. PubMed ID: 25504743
    [Abstract] [Full Text] [Related]

  • 20. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb 25; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.